Home/Filings/4/0001209191-18-045755
4//SEC Filing

Tursi James Patrick 4

Accession 0001209191-18-045755

CIK 0001016169other

Filed

Aug 6, 8:00 PM ET

Accepted

Aug 7, 6:14 PM ET

Size

5.9 KB

Accession

0001209191-18-045755

Insider Transaction Report

Form 4
Period: 2018-08-06
Tursi James Patrick
EVP, Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2018-08-06+150,000150,000 total
    Exercise: $2.89Exp: 2028-08-06Common Stock (150,000 underlying)
Footnotes (2)
  • [F1]Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. 2008 Equity Compensation Plan.
  • [F2]The options vest in equal quarterly installments over three years from the date of grant.

Issuer

ANTARES PHARMA, INC.

CIK 0001016169

Entity typeother

Related Parties

1
  • filerCIK 0001527710

Filing Metadata

Form type
4
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 6:14 PM ET
Size
5.9 KB